Search Results - Nunn, Aimie

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Analysis of the Modified Rankin Scale in Randomised Controlled Trials of Acute Ischaemic Stroke: A Systematic Review

    Analysis of the Modified Rankin Scale in Randomised Controlled Trials of Acute Ischaemic Stroke: A Systematic Review by Nunn, Aimie, Gray, Laura, Bath, Philip M. W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2)

    Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2) by Wiendl, Heinz, Foley, John, Defer, Gilles, Zhovtis Ryerson, Lana, Cohen, Jeffrey A., Arnold, Douglas L., Butzkueven, Helmut, Cutter, Gary R., Giovannoni, Gavin, Killestein, Joep, Domingo-Horne, Rose, Toukam, Marie, Nunn, Aimie, Maghzi, Amir-Hadi, Kuhelj, Robert, Lasky, Tyler

    Published in Neurology and therapy
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Identification and evaluation of novel methods for the analysis of ordinal data in acute stroke trials in comparison to ordinal logistic regression

    Identification and evaluation of novel methods for the analysis of ordinal data in acute stroke trials in comparison to ordinal logistic regression by Nunn, Aimie, Gray, Laura

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Analysis of the modified rankin scale in randomised controlled trials in acute stroke: a systematic review

    Analysis of the modified rankin scale in randomised controlled trials in acute stroke: a systematic review by Nunn, Aimie, Gray, Laura

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Résultats de l’étude d’extension NOVA évaluant la préférence des patients pour l’administration sous-cutanée (SC) versus intraveineuse (IV) de natalizumab (NTZ) avec le schéma Q6W (toutes les 6 semaines)

    Résultats de l’étude d’extension NOVA évaluant la préférence des patients pour l’administration sous-cutanée (SC) versus intraveineuse (IV) de natalizumab (NTZ) avec le schéma Q6W... by Wiendl, Heinz, Foley, John, Defer, Gilles, Ryerson, Lana Zhovtis, Cohen, Jeffrey A., Arnold, Douglas, Butzkueven, Helmut, Cutter, Gary, Giovannoni, Gavin, Killestein, Joep, Domingo-Horne, Rose, Toukam, Marie, Nunn, Aimie, Sinks, Susie, Maghzi, Amir-Hadi, Kuhelj, Robert, Lasky, Tyler

    Published in Revue neurologique
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: